It is a pharma private limited company based in Ambernath, Maharashtra, India, established in 2022.
2022 | Ambernath, Maharashtra, India | ActiveNcole Pharmaceuticals Private Limited, a active private limited company, was established on 03 November 2022 in Ambernath, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24290MH2022PTC393062. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Amit Dinesh Agarwal (Director), Gulam Mohiuddin Aslam Shaikh (Director), Syed Azmatullah Syed Peerpasha Peerzade (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F No - 06, Plot No - 34, Khaitan Bhavan, Ambernath, Maharashtra, 421501.
U24290MH2022PTC393062
393062
03 November 2022
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ncole Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Dinesh Agarwal | Director | 03 Nov 2022 | Current |
| Gulam Mohiuddin Aslam Shaikh | Director | 03 Nov 2022 | Current |
| Syed Azmatullah Syed Peerpasha Peerzade | Director | 03 Nov 2022 | Current |
| Ramdhani Ramkishor Yadav | Director | 03 Nov 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ncole Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ncole Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ncole Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ncole Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ncole Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ncole Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Ncole Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Amit Dinesh Agarwal was appointed as a Director was appointed as a Director on 03 Nov 2022 & has been associated with this company since 3 years 29 days . was recorded as a recent event.
Progress on Gulam Mohiuddin Aslam Shaikh was appointed as a Director was appointed as a Director on 03 Nov 2022 & has been associated with this company since 3 years 29 days . was documented.
Progress on Syed Azmatullah Syed Peerpasha Peerzade was appointed as a Director was appointed as a Director on 03 Nov 2022 & has been associated with this company since 3 years 29 days . was documented.
Progress on Ramdhani Ramkishor Yadav was appointed as a Director was appointed as a Director on 03 Nov 2022 & has been associated with this company since 3 years 29 days . was documented.
The CIN of Ncole Pharmaceuticals Private Limited is U24290MH2022PTC393062.
Ncole Pharmaceuticals Private Limited is headquartered at F No - 06, Plot No - 34, Khaitan Bhavan, Ambernath, Maharashtra, 421501.
Ncole Pharmaceuticals Private Limited was incorporated on 03 November 2022.
The current directors of Ncole Pharmaceuticals Private Limited are
The primary industry of Ncole Pharmaceuticals Private Limited is Manufacturing.
Ncole Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ncole Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Ncole Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX